LUXEMBOURG – Exobiosphere, a leading innovator in space-based high-throughput screening for drug discovery, is excited to announce its acceptance into the highly competitive House of BioHealth's BioIncubator in Luxembourg. With cutting-edge facilities and resources dedicated to advancing biotech, digital health, and space health innovation, this milestone enables Exobiosphere to accelerate its mission of revolutionizing drug discovery by leveraging microgravity for unprecedented breakthroughs in the pharmaceutical and biotech sectors.

Luxembourg, October 2024 – Exobiosphere, a pioneering company leveraging biotechnology in space for pharmaceutical and skincare innovation, is proud to announce its selection as one of the 20 startups chosen for the prestigious 12th edition of Luxembourg’s Fit 4 Start accelerator program. This recognition reaffirms Exobiosphere's role in revolutionizing high-throughput drug discovery and cutting-edge formulations through microgravity research.